Now showing items 1-4 of 4

    • A Systematic Review of Conceptual Frameworks of Medical Complexity and New Model Development. 

      Akushevich, Igor; Beadles, Christopher A; Hastings, Susan Nicole; Kravchenko, J; Maciejewski, Matthew Leonard; Whitson, Heather Elizabeth; Zullig, Leah L (J Gen Intern Med, 2016-03)
      BACKGROUND: Patient complexity is often operationalized by counting multiple chronic conditions (MCC) without considering contextual factors that can affect patient risk for adverse outcomes. OBJECTIVE: Our objective was ...
    • Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer's Disease. 

      Belger, M; Happich, M; Johnson, FR; Mühlbacher, Axel C; Yang, JC (Value Health, 2016-01)
      OBJECTIVE: The diagnosis of Alzheimer's disease (AD) remains difficult. Lack of diagnostic certainty or possible distress related to a positive result from diagnostic testing could limit the application of new testing ...
    • Population-based biobank participants' preferences for receiving genetic test results. 

      Tokutomi, Tomoharu; Yamamoto, Kayono; Hachiya, Tsuyoshi; Fukushima, Akimune; Nakaya, Naoki; Okayama, Akira; Tanno, Kozo; ... (10 authors) (Journal of human genetics, 2017-12)
      There are ongoing debates on issues relating to returning individual research results (IRRs) and incidental findings (IFs) generated by genetic research in population-based biobanks. To understand how to appropriately return ...
    • Risk communication in clinical trials: a cognitive experiment and a survey. 

      Cheung, YB; Goh, Cynthia; Pietrobon, Ricardo Santos; Tan, SB; Thumboo, J; Toh, HC; Wee, HL; ... (8 authors) (BMC Med Inform Decis Mak, 2010-09-27)
      BACKGROUND: A Royal Statistical Society Working Party recently recommended that "Greater use should be made of numerical, as opposed to verbal, descriptions of risk" in first-in-man clinical trials. This echoed the view ...